Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †

A number of monoclonal antibodies (mAb) are now under investigation in clinical trials to assess their potential role in Systemic Lupus Erythematosus (SLE). The most frequently used mAb is rituximab, which is directed against CD20, a membrane protein expressed on B lymphocytes. Uncontrolled trials r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponticelli, Claudio, Moroni, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991031/
https://www.ncbi.nlm.nih.gov/pubmed/27713252
http://dx.doi.org/10.3390/ph3010300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991031/
https://www.ncbi.nlm.nih.gov/pubmed/27713252
http://dx.doi.org/10.3390/ph3010300

Ejemplares similares